The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.
about
Minireview: nesfatin-1--an emerging new player in the brain-gut, endocrine, and metabolic axisThe role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavorsNeural circuitry underlying the central hypertensive action of nesfatin-1: melanocortins, corticotropin-releasing hormone, and oxytocinSelective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide.The brain melanocortin system, sympathetic control, and obesity hypertension.Molecular, cellular and physiological evidences for the anorexigenic actions of nesfatin-1 in goldfishRole of oxytocin signaling in the regulation of body weight.Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.Nesfatin-1 as a new potent regulator in reproductive system.Neuronostatin acts in brain to biphasically increase mean arterial pressure through sympatho-activation followed by vasopressin secretion: the role of melanocortin receptors.Melanocortin control of energy balance: evidence from rodent models.Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.Medial nucleus tractus solitarius oxytocin receptor signaling and food intake control: the role of gastrointestinal satiation signal processing.Nesfatin-1: role as possible new anti-obesity treatment.Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food IntakePeripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.Gastric peptides and their regulation of hunger and satiety.Coming full circle: contributions of central and peripheral oxytocin actions to energy balancePVN pathways controlling energy homeostasis.Oxytocin, feeding, and satiety.Neutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment.mTOR-dependent modulation of gastric nesfatin-1/NUCB2.Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptorsIncreased serum levels and chondrocyte expression of nesfatin-1 in patients with osteoarthritis and its relation with BMI, hsCRP, and IL-18.Role of Brain NUCB2/nesfatin-1 in the Stress-induced Modulation of Gastrointestinal Functions.Nesfatin-1: a novel inhibitory regulator of food intake and body weightNesfatin-1--role as possible new potent regulator of food intake.Multi-functional peptide hormone NUCB2/nesfatin-1.Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.Sex-specific differences in cardiovascular and metabolic hormones with integrated signalling in the paraventricular nucleus of the hypothalamus.Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.Increased blood pressure in nesfatin/nuclebindin-2-transgenic mice.Long-term infusion of nesfatin-1 causes a sustained regulation of whole-body energy homeostasis of male Fischer 344 rats.Lipopolysaccharide increases gastric and circulating NUCB2/nesfatin-1 concentrations in rats.Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis.Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals.The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin
P2860
Q24634803-054E6F3C-2E25-44C1-A008-EDB41E69F835Q27028004-D2BD0228-0925-42C0-BC4F-1B957E93D3C6Q33628107-944D5D79-65A1-4148-8932-F60EF2A27B88Q33704868-0A78F14A-6823-4AFD-8CB5-B30EEF8A7DEEQ33716111-8141348C-3249-40CA-AE0E-3A081FD03C67Q33769466-91464C3E-C82F-437B-8CC1-9099815C0B6FQ34425122-FAFB2B38-2A32-46BE-A708-4F0AF7CDAED4Q34630209-62BDF270-A449-4BC5-8883-70951C753792Q34804499-BC6E75C8-3A07-4422-85CB-2A465A21BCCBQ34979573-0DD53ABC-92D7-4FA9-AE3E-EFDF925C650DQ35103464-94998115-DA3B-42D9-8F7B-D3DAD7883BA0Q35411868-E7917E66-95DE-4426-A962-FD5F410751FFQ35560296-26D178E3-468A-4F39-AD72-23C01498787AQ35574605-1CA760FB-7E0F-4AC1-8495-1ECF7F5C5A53Q35726819-ED0EACDB-B978-41D6-882C-81AFB2BE944BQ35885897-318E2092-A34F-46EE-80C9-82261F89C176Q35893362-49A688B1-37CF-4ED1-A60D-671ECD677DC6Q36124372-5BAF5156-2DC0-400A-AE4D-E65FB8FF1D00Q36309549-BFF31C65-09F4-46E2-A2C8-5FF6CB9357BBQ36350655-5C573139-1D9F-45FA-A682-22016473B883Q36542883-424D4600-E20C-4115-983F-AB10E1390EE1Q36700916-E3D6180E-5806-47E9-9DFC-5DC73FC35E78Q36701924-D5AAB1F8-4C71-49C4-9847-60D14CD255A3Q36797348-BBF37071-DEAF-47D8-B894-421725B3AC7BQ37013458-92DF0EF3-E65D-4589-B7A1-5B566E25D189Q37087688-6E7A5A5C-C5B2-405C-822B-367B75A70E8CQ37292255-0D89F59E-32B5-4CF2-9DEE-96B7CE0CD445Q37677029-718C5B58-D843-4503-BBF0-78032E6B008CQ37764928-28BC7404-4892-4B58-BD8B-D20A64E8280AQ37767920-B696823C-26F1-49A1-8EE2-517D1085BB20Q38092747-14302F06-4F1A-489D-854A-F5DF5E2FCBFBQ38139312-E564E688-0CD3-4D34-B366-AE37B9F83382Q38649785-B0E15EC0-B815-40ED-B7D8-FAD83C2D19ADQ38667872-26708BB8-F25D-4741-B254-0A62FE90980CQ38817960-3D09146D-6E58-4592-BEAC-805EA762E2ADQ39383498-4F11278C-DEBB-4295-99E7-C34F8269B72AQ40688000-6B8A4CF3-178B-4801-A685-A150A06A7DC6Q41308321-8C64EC20-0C7D-48C2-A2F6-AD1AA96EC6B7Q41483576-4C9D4F49-09D2-47D2-8417-A386DC483731Q41774719-3077D24A-7EF1-4839-91C9-E297EBF48B4E
P2860
The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@ast
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@en
type
label
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@ast
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@en
prefLabel
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@ast
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@en
P2860
P1476
The anorexigenic and hypertens ...... oxytocin receptor antagonist.
@en
P2093
Gina L C Yosten
Willis K Samson
P2860
P304
P356
10.1152/AJPREGU.00804.2009
P577
2010-03-24T00:00:00Z